Skip to content

Clinical trials

Phase 3 Pancreatic Neoplasms trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pancreatic Neoplasms Phase: Phase 3 Country / region: Belgium Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20051
20063
20072
20093
20111
20131
20144
20161
20171
20241
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Terminated6
Recruiting2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Celgene2
Eli Lilly and Company2
Incyte Corporation2
Sanofi2
AB Science1
Arcus Biosciences, Inc.1
AstraZeneca1
Baki Topal1
European Organisation for Research and Treatment of Cancer - EORTC1
Gilead Sciences1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pancreatic Neoplasms24
Neoplasms5
Adenocarcinoma3
Endocrine Gland Neoplasms3
Digestive System Diseases2
Digestive System Neoplasms2
Endocrine System Diseases2
Neoplasm Metastasis2
Neoplasms by Site2
Pancreatic Diseases2

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.